statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge

EyePoint Pharmaceuticals reveals Phase 2 PAVIA trial results for Duravyu in non-proliferative diabetic retinopathy. Positive data showcases Duravyu's efficacy and safety profile.
read more...

Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?

- Charles Wykoff, M.D., Ph.D. joins Carl Regillo, M.D., FACS as co-chair of Scientific Advisory Board - Usha Chakravarthy, M.B.B.S, PhD., Allen Ho, M.D. FACS FASRS and Frank Holz, M.D., F.E.B.O...

EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists

This is a signal that EYPT's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

EyePoint Pharmaceuticals (EYPT, $20.27) RSI Indicator left the oversold zone on April 01, 2024

For the last three days, A.I.dvisor has detected that EYPT's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

EyePoint Pharmaceuticals (EYPT, $20.27) Aroon Indicator entered a Downtrend on April 01, 2024.

EyePoint Pharmaceuticals, Inc. ( NASDAQ:EYPT ) shares have had a horrible month, losing 26% after a relatively good...

More Unpleasant Surprises Could Be In Store For EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT) Shares After Tumbling 26%

EyePoint Pharmaceuticals (EYPT, $20.63) Aroon Indicator entered a Downtrend on March 28, 2024.

EyePoint Pharmaceuticals (EYPT, $20.79) RSI Indicator left the oversold zone on March 27, 2024

EyePoint Pharmaceuticals (EYPT, $20.79) Aroon Indicator entered a Downtrend on March 27, 2024.

This is a signal that EYPT's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

EyePoint Pharmaceuticals (EYPT, $20.6) Stochastic Oscillator left the oversold zone on March 26, 2024

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Pharmaceuticals Inc

Watchers	8,698
52-Wk Low	$5.67
52-Wk High	$30.99

Volume	1.04M
52-Wk High	$30.99
52-Wk Low	$5.67

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.51	--	--	N/A
Q1'24	-$0.40	-$0.55	-36.82%	MISSED
Q4'23	-$0.49	-$0.33	32.15%	BEAT
Q3'23	-$0.50	-$0.33	33.67%	BEAT
Q2'23	$1.38	-$0.61	-144.08%	MISSED

EYPT EyePoint Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals